Royce & Associates LP Has $45.57 Million Position in Enovis Co. (NYSE:ENOV)
Royce & Associates LP Has $45.57 Million Position in Enovis Co. (NYSE:ENOV)
Royce & Associates LP lifted its holdings in Enovis Co. (NYSE:ENOV – Get Rating) by 58.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 989,227 shares of the company's stock after purchasing an additional 363,928 shares during the period. Royce & Associates LP owned 1.83% of Enovis worth $45,574,000 at the end of the most recent reporting period.
Royce&Associates LP在最近提交給美國證券交易委員會(Securities And Exchange Commission)的13F文件中稱,該公司第三季度將其在Enovis Co.(NYSE:ENOV-GET評級)的持股比例提高了58.2%。該基金在此期間額外購買了363,928股後,持有該公司989,227股股票。在最近一次報告期結束時,Royce&Associates LP擁有Enovis 1.83%的股份,價值45,574,000美元。
Several other institutional investors and hedge funds have also modified their holdings of the business. Price T Rowe Associates Inc. MD acquired a new stake in shares of Enovis in the 2nd quarter valued at $333,199,000. Cooke & Bieler LP acquired a new position in Enovis during the 2nd quarter worth $86,274,000. State Street Corp acquired a new position in Enovis during the 2nd quarter worth $72,935,000. Eminence Capital LP acquired a new position in Enovis during the 2nd quarter worth $66,263,000. Finally, Millennium Management LLC acquired a new position in Enovis during the 2nd quarter worth $52,132,000. Institutional investors and hedge funds own 96.73% of the company's stock.
其他幾家機構投資者和對衝基金也調整了對該公司的持股。Price T Rowe Associates Inc.MD在第二季度收購了價值333,199,000美元的Enovis股票。Cooke&Bieler LP在第二季度收購了Enovis的一個新頭寸,價值86,274,000美元。道富銀行在第二季度收購了Enovis的一個新頭寸,價值72,935,000美元。卓越資本有限公司在第二季度收購了Enovis的一個新頭寸,價值66,263,000美元。最後,Millennium Management LLC在第二季度收購了Enovis的一個新頭寸,價值52,132,000美元。機構投資者和對衝基金持有該公司96.73%的股票。
Insider Buying and Selling at Enovis
Enovis的內幕買賣
In other Enovis news, CFO Christopher M. Hix sold 1,367 shares of the business's stock in a transaction dated Wednesday, December 14th. The shares were sold at an average price of $55.28, for a total value of $75,567.76. Following the transaction, the chief financial officer now directly owns 44,605 shares in the company, valued at $2,465,764.40. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, EVP Daniel A. Pryor sold 67,421 shares of the company's stock in a transaction that occurred on Tuesday, November 15th. The shares were sold at an average price of $54.58, for a total transaction of $3,679,838.18. Following the transaction, the executive vice president now directly owns 75,731 shares in the company, valued at $4,133,397.98. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Christopher M. Hix sold 1,367 shares of the company's stock in a transaction that occurred on Wednesday, December 14th. The stock was sold at an average price of $55.28, for a total transaction of $75,567.76. Following the transaction, the chief financial officer now owns 44,605 shares in the company, valued at $2,465,764.40. The disclosure for this sale can be found here. Company insiders own 8.30% of the company's stock.
在Enovis的其他消息中,首席財務官Christopher M.Hix在12月14日星期三的交易中出售了1,367股Enovis股票。這些股票的平均價格為55.28美元,總價值為75,567.76美元。交易完成後,這位首席財務官現在直接持有該公司44,605股股票,價值2,465,764.40美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過這個環節。在其他新聞方面,執行副總裁Daniel·普賴爾在11月15日星期二的一筆交易中出售了67,421股該公司股票。這些股票的平均價格為54.58美元,總成交金額為3,679,838.18美元。交易完成後,執行副總裁總裁現在直接持有該公司75,731股股份,價值4133,397.98美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站。此外,首席財務官克里斯托弗·M·希克斯在12月14日(星期三)的一次交易中出售了1,367股公司股票。該股以55.28美元的平均價格出售,總成交金額為75567.76美元。交易完成後,這位首席財務官現在擁有該公司44,605股股票,價值2,465,764.40美元。關於這次銷售的披露可以找到這裏。公司內部人士持有該公司8.30%的股份。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
Enovis Stock Up 0.8 %
Enovis股價上漲0.8%
NYSE ENOV opened at $58.37 on Thursday. The stock has a market cap of $3.16 billion, a P/E ratio of 121.61 and a beta of 1.99. The company's 50-day simple moving average is $55.14 and its 200 day simple moving average is $53.34. Enovis Co. has a twelve month low of $43.88 and a twelve month high of $134.43.
紐約證交所ENOV週四開盤報58.37美元。該股市值為31.6億美元,市盈率為121.61,貝塔係數為1.99%。該公司的50日簡單移動均線切入位在55.14美元,200日簡單移動均線切入位在53.34美元。Enovis Co.股價跌至43.88美元的12個月低點,以及134.43美元的12個月高點。
Enovis (NYSE:ENOV – Get Rating) last released its quarterly earnings results on Wednesday, November 2nd. The company reported $0.59 EPS for the quarter, beating analysts' consensus estimates of $0.47 by $0.12. The firm had revenue of $383.81 million for the quarter, compared to analyst estimates of $379.75 million. Enovis had a net margin of 0.94% and a return on equity of 4.46%. Research analysts anticipate that Enovis Co. will post 2.24 earnings per share for the current year.
Enovis(紐約證券交易所代碼:ENOV-GET Rating)最近一次發佈季度收益報告是在11月2日星期三。該公司公佈本季度每股收益為0.59美元,比分析師普遍預期的0.47美元高出0.12美元。該公司本季度營收為3.8381億美元,而分析師預期為3.7975億美元。Enovis的淨利潤率為0.94%,股本回報率為4.46%。研究分析師預計,Enovis Co.本年度每股收益將達到2.24歐元。
About Enovis
關於Enovis
(Get Rating)
(獲取評級)
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries.
Enovis公司是一家全球性的醫療技術公司。該公司開發、製造和分銷醫療器械產品,供整形外科專家、外科醫生、初級保健醫生、疼痛管理專家、物理治療師、足科醫生、脊椎按摩師、運動訓練師和其他醫療保健專業人員使用,以治療因退行性疾病、畸形、創傷事件和運動相關傷害而導致的肌肉骨骼疾病患者。
Read More
閲讀更多內容
- Get a free copy of the StockNews.com research report on Enovis (ENOV)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
- 免費獲取StockNews.com關於Enovis的研究報告(ENOV)
- 寶潔收益:一場值得冒險的賭博
- 股市下滑,經濟報告為經濟描繪黯淡圖景
- 如新控股股票與沃倫·巴菲特有什麼關係?
- J.B.亨特買房,物流公司成為焦點
- 英特爾股票是否即將突破?
Receive News & Ratings for Enovis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovis and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Enovis Daily》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Enovis和相關公司的最新新聞和分析師評級的每日簡要摘要。